Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02339740
Title Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group
Indications

acute promyelocytic leukemia

Therapies

Cytarabine + Dexamethasone + Idarubicin + Mitoxantrone

Arsenic trioxide + Gemtuzumab ozogamicin + Tretinoin

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.